Chetram Persaud
Virtus Investment Advisers, Llc
Assets Managed
$362.527M
Holdings
450
Last Quarter
2026 - Q1
Filed Date
16d ago
Growth Rate
-1.46%(2Q avg: 1.95%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Virtus Investment Advisers, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 450 positions.
Assets under management
The assets under management (AUM) of Virtus Investment Advisers, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 362.527M in assets, with a quarterly growth rate of -1.46% and a 2-quarter average growth rate of 1.95%. The portfolio is managed by Chetram Persaud, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
GILD Gilead Sciences Inc
| 0.79% | $2.853M 20,473 shares@ $139.37 avg price | Increased 260.76% |
AMGN Amgen Inc
| 0.79% | $2.835M 8,056 shares@ $351.86 avg price | Increased 274.7% |
REGN Regeneron Pharmaceuticals
| 0.77% | $2.78M 3,598 shares@ $772.65 avg price | Increased 290.67% |
IBRX Immunitybio Inc
| 0.76% | $2.744M 357,747 shares@ $7.67 avg price | Increased 23.54% |
VRTX Vertex Pharmaceuticals Inc
| 0.73% | $2.621M 5,869 shares@ $446.54 avg price | Increased 288.42% |
INCY Incyte Corp
| 0.71% | $2.559M 27,189 shares@ $94.13 avg price | Decreased -2.8% |
VRT Vertiv Holdings Co-a
| 0.7% | $2.513M 10,030 shares@ $250.58 avg price | Increased 0.21% |
ALNY Alnylam Pharmaceuticals Inc
| 0.69% | $2.472M 7,471 shares@ $330.88 avg price | Increased 335.12% |
EIX Edison International
| 0.67% | $2.412M 32,966 shares@ $73.19 avg price | Increased 1129.16% |
ROST Ross Stores Inc
| 0.61% | $2.21M 10,202 shares@ $216.63 avg price | Decreased -14.04% |
1-10 of 450